About Aptus Endosystems
Aptus Endosystems is a company based in Sunnyvale (United States) founded in 2002 was acquired by Medtronic in June 2015. Aptus Endosystems has raised $70 million across 3 funding rounds from investors including Medtronic, Synergy Life Science Partner and VCDE Venture Partners. The company has 63 employees as of December 31, 2022. Aptus Endosystems operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Remon Medical, among others.
- Headquarter Sunnyvale, United States
- Employees 63 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aptus Endosystems, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aptus Endosystems
Aptus Endosystems has successfully raised a total of $70M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aptus Endosystems
Aptus Endosystems has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Synergy Life Science Partner and VCDE Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Tech focused growth stage VC firm investing in North America, Europe & Asia
|
Locked | Locked | Locked | |
|
Private equity firm focused on life science sector
|
Locked | Locked | Locked |
Investor details for Aptus Endosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aptus Endosystems
Investment portfolio details for Aptus Endosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aptus Endosystems
Detailed financials for Aptus Endosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aptus Endosystems Comparisons
Peer comparison for Aptus Endosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aptus Endosystems
Aptus Endosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Remon Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| Locked | Locked | Locked |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| Locked | Locked | Locked |
Designs and manufactures for endovascular aortic repair equipment
|
|
| Locked | Locked | Locked |
Endovascular devices for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
Detailed competitors of Aptus Endosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aptus Endosystems
Complete news archive for Aptus Endosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptus Endosystems
Aptus Endosystems was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Aptus Endosystems is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Aptus Endosystems is a funded company, having raised a total of $70M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Aptus Endosystems is 63.
Aptus Endosystems was established in 2002 in Sunnyvale, United States, as a medical device company. Attention is directed toward technologies for endovascular aortic aneurysm repair. Two systems have been created: the Heli-FX EndoAnchor System and the Heli-FX Thoracic EndoAnchor System. FDA 510(k) clearance and CE marking have been obtained for both, with availability in the United States and European Union.
Aptus Endosystems's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Aptus Endosystems has 7 investors. Key investors include Medtronic, Synergy Life Science Partner, VCDE Venture Partners, Longitude Capital, and USVP.